Bionovo Announces Presentation on Its Lead Anti-Cancer Compound at Upcoming San Antonio Breast Cancer Symposium
29th Nov 2005, 17:49 GMT
Bionovo announced that a poster presentation providing phase 1 results of its drug BZL101, in breast cancer, will be made on 12/8/2005 at the 28th Annual San Antonio Breast Cancer Symposium, which is taking place 12/8/2005-11 at the Henry B Gonzalez Convention Center in San Antonio, TX.
Bionovo Announces Presentation on Its Lead Anti-Cancer Compound at Upcoming San Antonio Breast Cancer Symposium related news:
- Sonus Pharmaceuticals to Present TOCOSOL Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium — Mammography News from StratCenter.com
- Sonus Pharmaceuticals to Present TOCOSOL(R) Paclitaxel Clinical Data in Metastatic Breast Cancer at San Antonio Breast Cancer Symposium — RedOrbit News - Health
- Cytokinetics Announces Interim Phase II Breast Cancer Data for Ispinesib Presented at San Antonio Breast Cancer Symposium — Radiology News from StratCenter.com
- Genomic Health Announces Oncotype DX Study Results Presented th Annual San Antonio Breast Cancer Symposium — Pharmaceuticals News from StratCenter.com
- The Susan G Komen Breast Cancer Foundation Names 2005 Recipients of Komen Brinker Award for Scientific Distinction — Mammography News from StratCenter.com
- Testing for breast cancer is getting more comfortable — The Cancer Blog
- Schering AG begins phase II trials of anticancer compound — Pharmaceutical Business Review Online
- NBA: San Antonio 90, LA Lakers 84 — Monsters and Critics News
- Callisto Pharmaceuticals Announces Poster Presentation on Atiprimod at Scientific Meeting in December — Pharmaceuticals News from StratCenter.com
- Found, A realistic battle with breast cancer — The Cancer Blog
Latest news from Radiology News from StratCenter.com:
- Genzyme increasing R&D presence in San Antonio area
- Eisai Breaks Ground for New Oncology Facility in Research Triangle Park
- Ashok Gupta, MD Joins the Physician Team at Desert Radiologists
- AMICAS Offers Free PACS Webinar for RSNA Attendees
- Enrollment Completed Utilizing Cytori's Adipose-Derived Stem Cell Technology for Treatment of Breast Cancer Complications
- Groundbreaking for Cancer Center on Premier Healh Campus - Middletown
- BSD Medical Sends Message of Hope at Largest Conference of US Radiation Oncologists
- Volcano to Offer 7.5M Shares
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies.
- Adherex Reports Q3 2006 Financial Results